| IFNG; interferon, gamma [KO: K04687] |
| IFNGR1; interferon gamma receptor 1 [KO: K05132] |
| IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1) [KO: K05133] |
| |
| |
| STAT1; signal transducer and activator of transcription 1, 91kDa [KO: K11220] |
| CIITA; class II, major histocompatibility complex, transactivator [KO: K08060] |
| HLA-DMA; major histocompatibility complex, class II, DM alpha [KO: K06752] |
| HLA-DMB; major histocompatibility complex, class II, DM beta [KO: K06752] |
| HLA-DOA; major histocompatibility complex, class II, DO alpha [KO: K06752] |
| HLA-DOB; major histocompatibility complex, class II, DO beta [KO: K06752] |
| HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO: K06752] |
| HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO: K06752] |
| HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO: K06752] |
| HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO: K06752] |
| HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO: K06752] |
| HLA-DRA; major histocompatibility complex, class II, DR alpha [KO: K06752] |
| HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO: K06752] |
| HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO: K06752] |
| HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO: K06752] |
| HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO: K06752] |
| HLA class II histocompatibility antigen; K06752 major histocompatibility complex, class II [KO: K06752] |
| HLA class II histocompatibility antigen; K06752 major histocompatibility complex, class II [KO: K06752] |
| HLA class II histocompatibility antigen; K06752 major histocompatibility complex, class II [KO: K06752] |
| HLA class II histocompatibility antigen; K06752 major histocompatibility complex, class II [KO: K06752] |
| IRGM; immunity-related GTPase family, M [KO: K14139] [EC:3.6.5.-] |
| |
| SOCS1; suppressor of cytokine signaling 1 [KO: K04694] |
| MYD88; myeloid differentiation primary response 88 [KO: K04729] |
| IRAK1; interleukin-1 receptor-associated kinase 1 [KO: K04730] [EC: 2.7.11.1] |
| IRAK4; interleukin-1 receptor-associated kinase 4 [KO: K04733] [EC: 2.7.11.1] |
| TRAF6; TNF receptor-associated factor 6, E3 ubiquitin protein ligase [KO: K03175] |
| MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO: K04427] [EC: 2.7.11.25] |
| TAB1; TGF-beta activated kinase 1/MAP3K7 binding protein 1 [KO: K04403] |
| TAB2; TGF-beta activated kinase 1/MAP3K7 binding protein 2 [KO: K04404] |
| |
| |
| |
| |
| |
| MAP2K3; mitogen-activated protein kinase kinase 3 [KO: K04432] [EC: 2.7.12.2] |
| MAP2K6; mitogen-activated protein kinase kinase 6 [KO: K04433] [EC: 2.7.12.2] |
| |
| |
| |
| |
| CHUK; conserved helix-loop-helix ubiquitous kinase [KO: K04467] [EC: 2.7.11.10] |
| IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta [KO: K07209] [EC: 2.7.11.10] |
| IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma [KO: K07210] |
| NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [KO: K04734] |
| NFKBIB; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta [KO: K02581] |
| NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [KO: K02580] |
| RELA; v-rel reticuloendotheliosis viral oncogene homolog A (avian) [KO: K04735] |
| IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) [KO: K05406] |
| IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) [KO: K05425] |
| TNF; tumor necrosis factor [KO: K03156] |
| BCL2; B-cell CLL/lymphoma 2 [KO: K02161] |
| BCL2L1; BCL2-like 1 [KO: K04570] |
| BIRC2; baculoviral IAP repeat containing 2 [KO: K16060] |
| BIRC3; baculoviral IAP repeat containing 3 [KO: K16060] |
| XIAP; X-linked inhibitor of apoptosis [KO: K04725] |
| BIRC7; baculoviral IAP repeat containing 7 [KO: K16061] |
| BIRC8; baculoviral IAP repeat containing 8 [KO: K16061] |
| LY96; lymphocyte antigen 96 [KO: K05400] |
| TLR4; toll-like receptor 4 [KO: K10160] |
| HSPA8; heat shock 70kDa protein 8 [KO: K03283] |
| HSPA1A; heat shock 70kDa protein 1A [KO: K03283] |
| HSPA2; heat shock 70kDa protein 2 [KO: K03283] |
| HSPA1L; heat shock 70kDa protein 1-like [KO: K03283] |
| HSPA1B; heat shock 70kDa protein 1B [KO: K03283] |
| HSPA6; heat shock 70kDa protein 6 (HSP70B') [KO: K03283] |
| TLR2; toll-like receptor 2 [KO: K10159] |
| LAMA1; laminin, alpha 1 [KO: K05637] |
| LAMA2; laminin, alpha 2 [KO: K05637] |
| LAMA3; laminin, alpha 3 [KO: K06240] |
| LAMA5; laminin, alpha 5 [KO: K06240] |
| LAMA4; laminin, alpha 4 [KO: K06241] |
| LAMB1; laminin, beta 1 [KO: K05636] |
| LAMB2; laminin, beta 2 (laminin S) [KO: K06243] |
| LAMB3; laminin, beta 3 [KO: K06244] |
| LAMB4; laminin, beta 4 [KO: K06245] |
| LAMC1; laminin, gamma 1 (formerly LAMB2) [KO: K05635] |
| LAMC2; laminin, gamma 2 [KO: K06246] |
| LAMC3; laminin, gamma 3 [KO: K06247] |
| ITGA6; integrin, alpha 6 [KO: K06485] |
| ITGB1; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) [KO: K05719] |
| LDLR; low density lipoprotein receptor [KO: K12473] |
| TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A [KO: K03158] |
| CASP8; caspase 8, apoptosis-related cysteine peptidase [KO: K04398] [EC: 3.4.22.61] |
| CASP3; caspase 3, apoptosis-related cysteine peptidase [KO: K02187] [EC: 3.4.22.56] |
| CYCS; cytochrome c, somatic [KO: K08738] |
| CASP9; caspase 9, apoptosis-related cysteine peptidase [KO: K04399] [EC: 3.4.22.62] |
| GNAI1; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 [KO: K04630] |
| GNAI3; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 [KO: K04630] |
| GNAI2; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 [KO: K04630] |
| GNAO1; guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O [KO: K04534] |
| PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha [KO: K00922] [EC: 2.7.1.153] |
| PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta [KO: K00922] [EC: 2.7.1.153] |
| PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta [KO: K00922] [EC: 2.7.1.153] |
| PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma [KO: K00922] [EC: 2.7.1.153] |
| PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha) [KO: K02649] |
| PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5 [KO: K02649] |
| PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta) [KO: K02649] |
| PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma) [KO: K02649] |
| PDK1; pyruvate dehydrogenase kinase, isozyme 1 [KO: K12077] [EC: 2.7.11.2] |
| AKT1; v-akt murine thymoma viral oncogene homolog 1 [KO: K04456] [EC: 2.7.11.1] |
| AKT2; v-akt murine thymoma viral oncogene homolog 2 [KO: K04456] [EC: 2.7.11.1] |
| AKT3; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) [KO: K04456] [EC: 2.7.11.1] |
| BAD; BCL2-associated agonist of cell death [KO: K02158] |
| CD40LG; CD40 ligand [KO: K03161] |
| CD40; CD40 molecule, TNF receptor superfamily member 5 [KO: K03160] |
| |
| CCR5; chemokine (C-C motif) receptor 5 (gene/pseudogene) [KO: K04180] |
| |
| IL10; interleukin 10 [KO: K05443] |
| IL10RA; interleukin 10 receptor, alpha [KO: K05134] |
| IL10RB; interleukin 10 receptor, beta [KO: K05135] |
| |
| STAT3; signal transducer and activator of transcription 3 (acute-phase response factor) [KO: K04692] |
| TGFB1; transforming growth factor, beta 1 [KO: K13375] |
| TGFB2; transforming growth factor, beta 2 [KO: K13376] |
| TGFB3; transforming growth factor, beta 3 [KO: K13377] |